Our Tamoxifen Citrate Tablets IP 20mg represent pharmaceutical excellence in selective estrogen receptor modulator therapy, manufactured using premium raw materials and advanced pr...
Our Tamoxifen Citrate Tablets IP 20mg represent pharmaceutical excellence in selective estrogen receptor modulator therapy, manufactured using premium raw materials and advanced production techniques to ensure consistent bioavailability and therapeutic efficacy. Each batch undergoes rigorous quality testing to verify chemical composition, dissolution rates, and stability parameters, complying with Indian Pharmacopoeia standards and packaged to maintain integrity throughout the supply chain. This unwavering commitment to quality makes our tablets a trusted choice for healthcare providers requiring reliable cancer treatment medications that deliver predictable clinical outcomes.
These tablets are extensively utilized in oncology departments, cancer treatment centers, and hospital pharmacies worldwide, serving as frontline therapy for hormone receptor-positive breast cancer cases across both private and public healthcare systems. Medical institutions value their consistent performance in adjuvant treatment protocols and preventive care programs, while specialized endocrine clinics and research institutions conducting women's health studies rely on their therapeutic reliability. Distribution networks include pharmaceutical wholesalers supplying clinics, hospitals, and retail pharmacies in domestic and international markets seeking proven cancer treatment solutions.
Business partners benefit from our commitment to product reliability and supply chain consistency, with volume-based pricing and flexible delivery schedules that meet diverse market needs. Our manufacturing processes incorporate multiple quality checkpoints ensuring every tablet meets specified potency and purity standards, while the product's shelf stability and batch-to-batch consistency reduce business risks for distributors and healthcare providers. We maintain comprehensive documentation and regulatory compliance support to facilitate smooth market entry and build lasting customer confidence in therapeutic outcomes.
Key Features:
- Precisely formulated 20mg dosage strength per tablet
- Manufactured using high-purity active pharmaceutical ingredients
- Complies with Indian Pharmacopoeia quality standards
- Produced in GMP-certified manufacturing facilities
- Rigorous quality testing for consistent therapeutic performance
Benefits:
- Reliable therapeutic outcomes for hormone-positive breast cancer treatment
- Consistent batch-to-batch quality and dosage accuracy
- Reduced business risk through stable shelf life and product consistency
- Compliance with international pharmaceutical standards
- Trusted performance in clinical and hospital settings